Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

Disseminated extrapulmonary Legionella pneumophila infection presenting with panniculitis: case report and literature review

BMC Infectious Diseases201818:467

https://doi.org/10.1186/s12879-018-3378-0

©  The Author(s). 2018

  • Received: 9 October 2017
  • Accepted: 10 September 2018
  • Published:
Open Peer Review reports

Abstract

Background

Legionellosis is a well-known cause of pneumonia. Primary cutaneous and subcutaneous infection caused by Legionella pneumophila is rare and the diagnosis is challenging.

Case presentation

A 38-year-old Thai woman with systemic lupus erythematosus and myasthenia gravis treated with prednisolone and azathioprine presented to our hospital with low-grade fever, diarrhea, and indurated skin lesions on both thighs. Initial examination showed plaques on both inner thighs. Magnetic resonance imaging showed myositis and swelling of the skin and subcutaneous tissue. Diagnosis of panniculitis due to L. pneumophila was carried out by histopathology, Gram stain, and 16S rRNA gene sequencing method of tissue biopsy from multiple sites on both thighs. Myocarditis was diagnosed by echocardiography. The final diagnosis was disseminated extrapulmonary legionellosis. Treatment comprised intravenous azithromycin for 3 weeks and the skin lesions, myositis and myocarditis resolved. Oral azithromycin and ciprofloxacin were continued for 3 months to ensure eradication of the organism. The patient’s overall condition improved.

Conclusions

To our knowledge, we report the first case of L. pneumophila infection manifesting with panniculitis, possible myositis, and myocarditis in the absence of pneumonia. The diagnosis of extrapulmonary Legionella infection is difficult, especially in the absence of pneumonia. A high index of suspicion and appropriate culture with special media or molecular testing are required. Initiation of appropriate treatment is critical because delaying therapy was associated with progressive infection in our patient.

Keywords

  • Legionella pneumophila
  • Panniculitis
  • Lupus
  • Myositis
  • Myocarditis

Background

Legionella is a well-known cause of pneumonia. Extrapulmonary manifestations of Legionnaires’ disease include myocarditis [1, 2], neurological involvement (acute disseminated encephalomyelitis), and multiorgan failure [3, 4]. Legionnaires’ disease has been reported together with several types of skin lesions such as maculopapular rash, petechial rash, erythema with focal blister, cellulitis, pustules, abscesses, and subcutaneous masses [5]. Various species of Legionella, including L. pneumophila, L. micdadei, L. cincinnatiensis, L. maceachernii, and L. feeleii, cause skin/soft tissue infection, mostly among immunocompromised patients with pneumonia [6]. Primary cutaneous infection is a rare distinctive feature of direct inoculation of Legionella into skin and soft tissue, which occurs as cellulitis necrotizing fasciitis, as a postoperative complication [6–9]. The diagnosis of legionellosis can be challenging in the absence of pneumonia. To the best of our knowledge, this is the first description of panniculitis due to Legionella. This report highlights the challenges, pitfalls and importance of diagnosing extrapulmonary Legionella infection.

Case presentation

We describe a case of disseminated extrapulmonary legionellosis in an immunocompromised 38-year-old Thai woman. The patient was diagnosed in 2002 with systemic lupus erythematosus (SLE) with fever, polyarthritis, oral ulcer, alopecia, and proteinuria. Since then, she has been treated with prednisolone with azathioprine. She achieved clinical remission but remained on prednisolone (5 mg daily) and azathioprine (50 mg daily) for 13 years. In August 2015, 3 months prior to admission, she suffered from cramping abdominal pain, watery diarrhea two or three times daily, and low-grade fever. She was diagnosed with enteritis and treated with ceftriaxone without clinical improvement. The dose of immunosuppressive medication was increased to prednisolone 45 mg daily and hydroxychloroquine 400 mg daily. In September 2015, 2 months prior to admission, she developed proximal muscle weakness with low-grade fever. She was diagnosed with myasthenia gravis and received treatment with pyridostigmine (Mestinon™) 240 mg daily. She remained weak and lost significant weight because of poor appetite and diarrhea. She was admitted to her local hospital in October 2015 for intravenous fluid hydration and pyridostigmine was discontinued because of diarrhea. As her condition was becoming increasingly compromised with high-grade fever, generalized vesicular rash, and proximal muscle weakness, she was referred to our hospital in November, 2015. She did not recall any exposure to potentially contaminated water or animals. She worked as a school teacher. Upon admission, her temperature was 39 °C, heart rate 100 beats/min, and respiratory rate 20 breaths/min. Blood pressure was 90/60 mmHg. Physical examination revealed a cachectic woman with mild pale conjunctivae and anicteric sclerae. Skin examination showed generalized discrete erythematous papules and macules with dry necrotic crust on the scalp, facial area, trunk and extremities. She also had plaques measuring 15 × 15 cm on both inner thighs (Fig. 1). Abdominal examination showed mild tenderness and distension. The examination did not reveal any cardiac or pulmonary findings. Neurological examination revealed ptosis in both eyes, proximal muscle weakness (grade IV) of all extremities, but normal sensation and tendon reflexes. Laboratory data shown in Table 1. Skin biopsy of the crusted lesion revealed varicella zoster virus from polymerase chain reaction (PCR). She was diagnosed with varicella zoster virus infection. At admission, plasma cytomegalovirus (CMV) viral load (Cobas® Taqman amplicon) was 363,000 copies/mm3. She received intravenous ganciclovir injection with adjuvant granulocyte colony-stimulating factor for leukopenia. The timeline of the patient’s illness is illustrated in Additional file 1. She was also treated empirically for skin and soft tissue infection with piperacillin/tazobactam (12 days), and then meropenem (5 days) and then cefepime (5 days), without any clinical response. Further investigations, computed tomography of the abdomen showed a long segment of jejunal wall thickening and mild rectal wall thickening. Colonoscopy revealed generalized edematous mucosa of the colon without ulceration, and random biopsy was negative. She was diagnosed with CMV syndrome with suspected CMV jejunitis, which later improved with ganciclovir therapy. She was also diagnosed with myasthenia gravis by electromyography, nerve conduction velocity, and presence of acetylcholine receptor antibody. Later on, she developed chest pain and shortness of breath. Computed tomography of the chest revealed bilateral pleural effusion and small pericardial effusion. Echocardiography revealed impaired left ventricular systolic function with 40% ejection fraction along with global hypokinesia. She was diagnosed with lupus myocarditis, and treated with a 5-day course of intravenous immunoglobulin (0.4 g/kg/day) and 5 mg/day intravenous dexamethasone. During her hospitalization for 21 days, she remained febrile with a maximum temperature of 38.5–39 °C, despite the previously mentioned therapy. At that time, she had worsening pain in both thighs at the site of the plaques. Magnetic resonance imaging of both lower extremities revealed diffuse enhancing, hyperintense T2 signals in the muscles at the pelvis at both thighs and legs, with diffuse muscle atrophy and swelling of the skin and subcutaneous tissue (Fig. 2a, b). Multiple subcutaneous biopsy specimens were taken from both thighs (site of skin lesions) showed suppurative panniculitis (Fig. 3) and presence of Gram-negative bacilli. Acid-fast and Gomori methenamine stains were negative. Tissue biopsies for aerobic microorganisms showed no growth. Bacterial broad-range 16S ribosomal RNA sequencings revealed L. pneumophila (99% similarity to L. pneumophila consensus sequence). Culture for fungi and mycobacteria was negative. Her antimicrobial regimen was changed to intravenous azithromycin, and fever subsided within 5 days. Her thigh lesions gradually improved over the first week of therapy (Fig. 4). She was diagnosed with disseminated L. pneumophila infection resulting in panniculitis, myositis and myocarditis. She received intravenous azithromycin for 21 days. Oral azithromycin and ciprofloxacin were continued for 3 months to ensure eradication of the organism from our immunosuppressed patient. She received intravenous ganciclovir until the clearance of CMV viremia (total of 48 days), and then switched to oral valganciclovir maintenance therapy. She underwent physical rehabilitation and was discharged after 64 days hospitalization. Clinically, she is doing well at 1-year follow-up. She did not have any further tests done as follow-up proved successful clinical resolution and eradication of Legionella infection.
Fig. 1
Fig. 1

Multiple erythematous indurated plaques on the proximal right thigh, multiple healed crusted papules on the right lower extremity, and whitish striae (before treatment)

Table 1

Laboratory data on admission

Parameter

Recorded value

Standard value

White blood cell count

1,860 cells/mm3

4,500–7,500 cells/mm3

Neutrophils

83 %

 

Lymphocytes

14 %

 

Hemoglobin

10.8 g/dL

11.3–15.2 g/dL

Hematocrit

32.4 %

36–45 %

Platelet count

179,000 cells/mm3

130,000–350,000 cells/mm3

Total protein

33 g/L

69-84 g/L

Albumin

12.3 g/L

39–51 g/L

Total bilirubin

0.6 mg/dL

0.2–1.2 mg/dL

Direct billirubin

0.3 mg/dL

0.1–0.3 mg/dL

Aspartate aminotransferase

23 U/L

11–30 U/L

Alanine aminotransferase

34 U/L

4–30 U/L

Alkaline phosphatase

57 U/L

44–147 U/L

Blood urea nitrogen

9.0 mg/dL

8–20 mg/dL

Creatinine

0.32 mg/dL

0.63–1.03 mg/dL

Fig. 2
Fig. 2

a. Coronal T2-weighted MRI of the thighs. b. Axial T2-weighted MRI of the thighs demonstrating enhancement of subcutaneous tissue and muscle. MRI, magnetic resonance imaging

Fig. 3
Fig. 3

Histopathology of subcutaneous tissue of right thigh. Photomicrograph revealed neutrophil infiltration in the deep dermis to subcutaneous tissue and fat necrosis (200×, hematoxylin and eosin)

Fig. 4
Fig. 4

Proximal right thigh showed resolution of indurated plaque after 8 days of treatment for Legionella, biopsy stiches, healed scar of varicella lesions, and whitish striae

Discussion

Here, we describe a patient with SLE and myasthenia gravis who suffered multiple infectious complications including varicella, CMV syndrome/jejunitis and Legionella panniculitis with possible dissemination (myositis and myocarditis). Panniculitis cause by Legionella has not been reported in the literature. Our initial presumptive diagnosis of panniculitis was lupus panniculitis or CMV related panniculitis. However, our patient did not improve during the course of treatment for both diseases. The diagnosis of lupus panniculitis should not be assumed in SLE patients, given that immunosuppressive drugs are a predisposing factor for infective panniculitis, and both conditions require different treatment strategies [10]. Infective panniculitis has been described in association with many infectious agents including bacteria (Nocardia spp. and Actinomyces spp.), mycobacteria, fungi and parasites [11]. Anatomical pathology is the key to distinguishing the etiology of panniculitis by the type of white blood cell infiltrates. Lupus panniculitis presents with lymphocytic infiltrates with or without vasculitis. CMV panniculitis must have evidence of viral cytopathic changes with the characteristic owl’s eye inclusion bodies. Our patient had neutrophilic panniculitis that suggested infective panniculitis. Gram staining showed intracellular Gram-negative bacilli that failed to grow on routine culture media, and they were identified as L. pneumophila by molecular methods. It was difficult to distinguish whether the panniculitis resulted from primary inoculation or secondary hematogenous spread of Legionella. Several features, such as prolonged fever despite broad-spectrum beta-lactam antibiotics, myositis and myocarditis, suggested disseminated Legionella infection. Myositis has been reported in one patient with pneumonia [12]. The etiology of myocarditis in our patient remains debatable, and whether it resulted from lupus or Legionella infection. Myocardial biopsy was not performed because of the excessive risk in our case, and therapy for both lupus and Legionella was initiated at the same time. Follow-up echocardiography showed normal cardiac function. Legionella myocarditis has been reported as a complication of Legionnaires’ disease [13, 14]. Only one adult patient developed perimyocarditis due to L. pneumophila in the absence of respiratory involvement, which resulted in multiorgan failure [1]. The atypical multiorgan involvement of Legionella infection in our patient could have resulted from immunosuppression that led to lymphopenia and cell-mediated immunodeficiency. Our patient did not have evidence of pneumonia at any time point before or during hospitalization.

Cutaneous and subcutaneous Legionella infection is rare and mostly occurs in immunosuppressed patients, as described previously [5]. Primary extrapulmonary infection of skin/subcutaneous tissue (cellulitis, multiple subcutaneous abscesses, and tenosynovitis) by L. pneumophila led to disseminated infection (pneumonia and respiratory failure) in an immunocompromised liver transplant recipient [15]. The diagnosis was made from culture of bronchoalveolar lavage fluid and later, Legionella was isolated from the abscesses using special culture media and was confirmed by molecular methods [15]. This highlights the challenging aspect in the diagnosis of Legionella infection, as it is a facultative Gram-negative aerobic bacillus that resides within tissue and alveolar macrophages, and it requires specialized media [16]. Non-culture-based diagnostic methods include urinary antigen tests for L. pneumophila, which is a rapid diagnostic tool; however, these tests are limited to the detection of L. pneumophila serogroup 1, L. micdadei and Legionella longbeachae [17].

The diagnosis of extrapulmonary Legionella infection relies on clinician alertness and a good level of cooperation with the microbiology laboratory, as Legionella species must be grown on special media. In our setting we did not have the selective media, Legionella urinary antigen and antibody to detect Legionella, or direct fluorescent antibody against Legionella. The diagnosis in our patient was made by 16S rRNA gene sequencing method. Initiation of appropriate treatment is critical because delay is associated with increased mortality in Legionella pneumonia [18]. Effective antimicrobial treatment of legionellosis includes antibiotics that achieve therapeutic intracellular concentrations within macrophages, such as the macrolides, fluoroquinolones, and cyclin families [16]. Azithromycin or levofloxacin are commonly used to treat Legionella infection [16, 19]. Optimal treatment duration for cutaneous legionellosis has not been established. Most patients with Legionella pneumonia are successfully treated with a 7-to 14-day course of antibiotics. Disseminated legionellosis requires longer duration of therapy, although the duration is not well defined. Immunocompromised patients with cutaneous legionellosis may require 3 weeks of treatment [5, 16].

Conclusion

Legionella infection may cause extrapulmonary manifestations involving skin/subcutaneous and muscle that leads to dissemination, especially in immunocompromised patients. Infective panniculitis caused by Legionella should be considered in the differential diagnosis of skin/subcutaneous infection that fails to respond to beta-lactam antibiotics. The diagnosis of extrapulmonary Legionella infection is challenging because special culture media are required. In our case, the diagnosis was based on 16S rRNA gene sequencing method. Clinicians should be aware of extrapulmonary manifestation of legionellosis in the absence of pneumonia.

Abbreviations

PCR: 

Polymerase chain reaction

rRNA: 

ribosomal ribonucleic acid

Declarations

Acknowledgements

We are grateful to Siriorn Watcharananan MD for helpful comment, Parawee Chevaisarakul MD for clinical management, Patawee Boontanon MD for providing the picture, Apichart Sudatis MD for data collection, Teerawut Sirikum MD for performing tissue biopsy, and Suthep Jirasuthat MD who gave an opinion on the pathological report. We thank Cathel Kerr, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

MNC drafted the manuscript. MNC and NR and were responsible for the clinical management and therapy. YV performed the histological examination of the tissue biopsy. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Committee on Human Rights Related to Research Involving Human Subjects, Faculty of Medicine Ramathibodi Hospital, Mahidol University.

Consent for publication

The patient gave written consent for publication of her potentially identifying information (including individual details and images).

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Infectious Disease, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi District, Bangkok, 10400, Thailand
(2)
Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
(3)
Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi District, Bangkok, Thailand

References

  1. Burke PT, Thabolingam R, Saba S. Suspected Legionella-induced Perimyocarditis in an adult in the absence of pneumonia: a rare clinical entity. Tex Heart Inst J. 2009;36(6):601–3.Google Scholar
  2. Ishimaru NS, Tokuda Y, Takano T. Severe legionnaires’ disease with pneumonia and biopsy-confirmed myocarditis Most likely caused by Legionella pneumophila Serogroup 6. Intern Med. 2012;51:3207–12.View ArticleGoogle Scholar
  3. Bodur H, Savran Y, Koca U, Kilinc O, Albayrak S, Itil O, Akoglu S. Legionella pneumonia with acute respiratory distress syndrome, myocarditis and septic shock successfully treated with Drotrecogin alpha (activated). Eur J Anaesthesiol. 2006;23(9):808–10.View ArticleGoogle Scholar
  4. Sommer JB, Erbguth FJ, Neundorfer B. Acute disseminated encephalomyelitis following Legionella pneumophila infection. Eur Neurol. 2000;44(3):182–4.Google Scholar
  5. Padrnos LJ, Kusne S, DiCaudo DJ, Mikhael JR. Cutaneous legionellosis: case report and review of the medical literature. Transpl Infect Dis. 2014;16:307–14.View ArticleGoogle Scholar
  6. Han JH, Harada S, Baddour LM, Edelstein PH, et al. Relapsing Legionella pneumophila cellulitis: a case report and review of the literature. J Infect Chemother. 2010;16(6):439–42.View ArticleGoogle Scholar
  7. Brabender W, Hinthorn DR, Asher M, Lindsey NJ, Liu C. Legionella pneumophila wound infection. JAMA. 1983;250(22):3091–2.View ArticleGoogle Scholar
  8. Kilborn JA, Manz LA, O'Brien M, Douglass MC, Horst HM, Kupin W, Fisher EJ. Necrotizing cellulitis caused by Legionella micdadei. Am J Med. 1992;92(1):104–6.View ArticleGoogle Scholar
  9. Loridant S, Lagier JC, La Scola B. Identification of Legionella feeleii cellulitis. Emer Infect Dis. 2011;17(1):145–6.Google Scholar
  10. Chan MP. Neutrophilic panniculitis: algorithmic approach to a heterogeneous group of disorders. Arch Pathol Lab Med. 2014;138(10):1337–43.View ArticleGoogle Scholar
  11. Morrison LK, Rapini R, Willison CB, Tyring S. Infection and panniculitis. Dermatol Ther. 2010;23(4):328–40.View ArticleGoogle Scholar
  12. Warner CL, Fayad PB, Heffner RR Jr. Legionella myositis. Neurology. 1991;41(5):750–2.View ArticleGoogle Scholar
  13. Gowani SA, Kumar A, Arora S, Lahiri B. Legionella pneumonia complicated by myocarditis and torsades de pointes: a case report and review of literature. Conn Med. 2013;77(6):331–4.Google Scholar
  14. Briceno DF, Fernando RR, Nathan S, Loyalka P, Kar B, Gregoric ID. TandemHeart as a bridge to recovery in Legionella myocarditis. Tex Heart Inst J. 2015;42(4):357–61.View ArticleGoogle Scholar
  15. Valve K, Vaalasti A, Anttila VJ, Vuento R. Disseminated Legionella pneumophila infection in an immunocompromised patient treated with tigecycline. Scand J Infect Dis. 2010;42(2):152–5.View ArticleGoogle Scholar
  16. Phin N, Parry-Ford F, Harrison T, Stagg HR, Zhang N, Kumar K, Lortholary O, Zumla A, Abubakar I. Epidemiology and clinical management of legionnaires’ disease. Lancet Infect Dis. 2014;14:1011–21.View ArticleGoogle Scholar
  17. Pierre DM, Baron J, Yu VL, Stout JE. Diagnostic testing for legionnaires’ disease. Ann Clin Microbiol Antimicrob. 2017;16:59.View ArticleGoogle Scholar
  18. Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis. 1996;15(4):286–90.View ArticleGoogle Scholar
  19. Pedro-Botet ML, Yu VL. Treatment strategies for Legionella infection. Expert Opin Pharmacother. 2009;10(7):1109–21.View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement

BMC Infectious Diseases

ISSN: 1471-2334

Contact us